EDGAR Filing Documents for 0001104659-17-009260

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001104659-17-009260

Filing Date

2017-02-14

Accepted

2017-02-14 16:07:33

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B3	a16-22161_1424b3.htm	424B3	147063
2	GRAPHIC	g221611bmi001.jpg	GRAPHIC	2305
3	GRAPHIC	g221611bmi002.gif	GRAPHIC	5474
4	GRAPHIC	g221611bwi001.jpg	GRAPHIC	2305
5	GRAPHIC	g221611bwi002.gif	GRAPHIC	5474
	Complete submission text file	0001104659-17-009260.txt		170274

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827

Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500

Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)